Frequent coauthors
- OHSHIMA ETSUO 102
- WATANABE Akihiko 102
- KIMOTO NAOYA 85
- MIYAKE KIYOMI 17
- WATANABE AKIKO 17
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.